Brief: Allergy Therapeutics Targeting HKEX Listing Effective First Half Of 2026
06/11/2025 08:16
Nov 6 (Reuters) - Allergy Therapeutics PLC AGY.L: ALLERGY THERAPEUTICS - COMPANY TO EVALUATE DUAL LISTING ON HKEX ALLERGY THERAPEUTICS PLC - TARGETING HKEX LISTING EFFECTIVE FIRST HALF OF 2026 Source text: ID:nRSF4682Ga Further company coverage: AGY.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update